Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	126,851	104,849	74,127	55,834	61,457	56,303
Market Cap Growth	33.30%	41.44%	32.76%	-9.15%	9.15%	32.95%
Enterprise Value	117,401	94,355	64,159	49,196	55,688	53,117
PE Ratio	31.90	28.97	22.31	23.84	22.66	47.84
PS Ratio	12.45	10.62	8.30	7.37	9.90	13.53
PB Ratio	6.84	5.96	5.33	5.53	7.08	9.25
P/FCF Ratio	34.12	31.42	18.88	23.18	20.53	37.69
P/OCF Ratio	32.16	29.64	17.95	21.12	18.89	35.88
EV/Sales Ratio	11.53	9.56	7.18	6.50	8.97	12.76
EV/EBITDA Ratio	23.45	20.49	14.46	16.86	16.95	34.04
EV/EBIT Ratio	24.41	21.33	14.97	17.62	17.54	36.55
EV/FCF Ratio	31.58	28.28	16.35	20.43	18.60	35.56
Debt / Equity Ratio	0.04	0.04	0.06	0.09	0.10	0.10
Debt / EBITDA Ratio	0.14	0.16	0.18	0.30	0.27	0.40
Debt / FCF Ratio	0.19	0.22	0.21	0.37	0.30	0.42
Quick Ratio	3.15	3.60	4.46	4.04	4.02	3.33
Current Ratio	3.50	3.99	4.83	4.46	4.33	3.61
Asset Turnover	0.46	0.47	0.55	0.60	0.59	0.57
Interest Coverage	111.61	100.32	78.23	45.40	54.55	24.84
Return on Equity (ROE)	23.60%	22.60%	26.70%	24.80%	35.20%	22.30%
Return on Assets (ROA)	18.10%	17.30%	20.50%	18.60%	25.70%	16.00%
Return on Capital (ROIC)	18.13%	17.07%	22.66%	21.70%	26.07%	15.12%
Earnings Yield	3.17%	3.45%	4.48%	4.19%	4.41%	2.09%
FCF Yield	2.93%	3.18%	5.30%	4.31%	4.87%	2.65%
Buyback Yield / Dilution	-0.31%	-0.54%	0.31%	1.33%	-1.04%	-0.58%
Total Shareholder Return	-0.31%	-0.54%	0.31%	1.33%	-1.04%	-0.58%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).